BCBinoy Varghese Cheriyan

Binoy Varghese Cheriyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Binoy Varghese Cheriyan has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immunopharmacological Targeting of Immune-Bone Crosstalk in Bone Disorders: Mechanisms and Therapeutic Perspectives

    by Kaniga Pandi, Binoy Varghese Cheriyan, Sudharshini Srinivasan, Praveen Kumar Ramesh, Bhuvanesh Raj, Preethi Harikrishnan, Sharmila Sakthisivanandhan, Jubilee Ramsamy, Yokesh Shanmugam, Maha Swetha Kannuchamy, et al.

    Bone remodeling is a tightly regulated physiological process governed by the coordinated activities of bone-forming osteoblasts and bone-resorbing osteoclasts. Emerging evidence highlights the immune system as a critical regulator of this process through complex cellular interactions and signaling networks, giving rise to the concept of osteoimmunology. Immune cells, including T cells, B cells, and macrophages, modulate bone homeostasis by secreting cytokines and engaging in direct cell-cell communication that influences osteoclast differentiation and osteoblast function. Key molecular pathways implicated in immune-mediated bone remodeling include the RANK-RANKL-OPG axis, Wnt/β-catenin signaling, and pro-inflammatory cytokine networks involving TNF-α, IL-6, and IL-17. Dysregulation of these pathways contributes to the pathogenesis of bone disorders such as osteoporosis, rheumatoid arthritis, and other inflammatory bone diseases. From a pharmaceutical perspective, targeting immune-bone signaling pathways has emerged as a promising therapeutic strategy. Approved biologics, including monoclonal antibodies against RANKL and inflammatory cytokines, have demonstrated clinical efficacy in reducing pathological bone resorption. In addition, emerging immunopharmacological approaches such as modulation of regulatory T cells, immune checkpoint signaling, and cytokine-driven intracellular pathways offer novel opportunities for drug development. Advances in precision medicine and immunotherapy further support the development of personalized interventions for immune-mediated bone disorders. This review critically examines immune-bone crosstalk with an emphasis on pharmacologically actionable targets and emerging therapeutic strategies, providing insights into future directions for restoring skeletal homeostasis and preventing immune-driven bone loss.

  • Open Access

    Mechanisms of Tumor Progression and Drug Resistance in Pancreatic Cancer Models (PANC-1, MiaPaCa-2, and BxPC-3 ) – A Review

    by Binoy Varghese Cheriyan, Kaniga Pandi, Kunal Rupesh Kumar Kataria, Yokesh Shanmugam, Maha Swetha Kannuchamy, Mahalakshmi Sundarraj, Kaviya Jothi Arumugasamy, Kaviyapriya Gopal Kuberaselvam, Praveen Kumar Ramesh, Bhuvanesh Raj

    Pancreatic cancer is one of the most lethal malignancies, accounting for approximately 3–4% of all cancers but nearly 7–8% of cancer-related deaths worldwide, with a 5-year survival rate of less than 12%. Its aggressive biology, early metastatic spread, and profound resistance to chemotherapy contribute to poor clinical outcomes. Due to these challenges, in vitro pancreatic cancer cell line models have become indispensable tools for elucidating molecular mechanisms underlying tumor progression and drug resistance. This review comprehensively evaluates three widely used pancreatic cancer cell lines PANC-1, MiaPaCa-2, and BxPC-3 highlighting their distinct molecular, phenotypic, and genetic characteristics and their relevance in anticancer drug discovery. PANC-1 cells, characterized by KRAS mutations and high mesenchymal marker expression, are extensively utilized to study epithelial–mesenchymal transition (EMT), migration, and invasiveness. MiaPaCa-2 cells exhibit enhanced glycolytic activity, stemness-associated markers, and pronounced chemoresistance, making them valuable for investigating cancer stem cell behavior and metabolic adaptations. In contrast, BxPC-3 cells, which are KRAS wild-type, serve as an important model for assessing drug sensitivity and therapeutic response mechanisms, particularly to gemcitabine and targeted agents. Comparative analyses across these models have significantly advanced understanding of key drug resistance pathways, including EMT-driven resistance, altered metabolic signaling, and survival pathway activation, and have facilitated preclinical screening of standard chemotherapeutics and emerging novel compounds. Furthermore, cross-model comparisons provide insights into tumor heterogeneity and support the identification of predictive biomarkers for therapeutic outcomes. Although conventional cell lines remain essential molecular tools, their inability to fully recapitulate the tumor microenvironment limits translational relevance. Therefore, integrating advanced systems such as organoids, patient-derived xenografts, and co-culture models is crucial to bridge the gap between preclinical research and clinical application and to improve therapeutic strategies for pancreatic cancer.

  • Therapeutic Potential of 3-Hydroxyflavone: Inducing Apoptosis and Modulating Inflammation in Lung Cancer A549 Cells

    by Binoy Varghese Cheriyan, Karthik K. Karunakar, V.K. Yuvasre, Kavya Kathiravan, Srinidhi K, Kaniga Pandi, Perumal Elumalai

    Lung cancer is a primary cause of cancer deaths globally. Flavonoids have anticancer qualities, although flavonol or 3-hydroxyflavone (3HF)’s effects on lung cancer are unknown. 3HF’s effects on cell viability, apoptosis, migration, and gene expression in human lung cancer A549 cells are examined to determine its anticancer and anti-inflammatory properties. A549 cells were treated with 3HF (25-250 μg/mL) and cytotoxicity was measured using MTT test. Phase-contrast microscopy examined morphological changes. Cell movement was measured by the scratch wound healing technique, and apoptotic cells were detected by AO/EtBr staining. Gene expression analysis for apoptotic and inflammatory markers was done with real-time PCR. Treatment with 3HF dramatically reduced cell viability, dose-dependently, with an IC5 0 value of 135 μg/mL. Apoptosis was shown by cell shrinkage and membrane blebbing. We also found considerable cell migration inhibition. AO/EtBr staining indicated increased apoptosis, whereas PCR analysis showed Bax and caspase-3 overexpression and Bcl-2, TNF-α, and NF-κB downregulation. This suggests 3HF is a promising lung cancer treatment.

  • Eco-Friendly Copper Nanoparticles Synthesized from Andrographis paniculata: A Potential Agent Against Breast Cancer

    by Binoy Varghese Cheriyan, D. Ishwariya, G. Prithi Jintha, R. Godson Samdevapriyan, S. Varsha, M. Abdur Raaziq, Mahalakshmi Devaraji


  • Open Access

    Traditional Chinese medicine–derived phytochemicals in prostate cancer: Mechanisms, progress, and prospects

    by Karthik K Karunakar, Kunal R Kataria, Lincy Yabase, Binoy Varghese Cheriyan, Keerthi Varsha, Sowmiya Philip


  • Open Access

    Bioinspired Selenium Nanoparticles as a Potential Anticancer Agent in Oral Squamous Cell Carcinoma: Apoptosis-Induced Cytotoxicity

    by Karthik Kadhiri Karunakar, Binoy Varghese Cheriyan, Bhavya E, Akshaya Murugathirumal, Abinaya Senthilkumar, Ragavendran Anandakumar, Gnanisha Murugan, Krithikeshvaran Rajasekaran, Rajeshkumar Shanumugam, Sowmyalakshmi Venkataraman, et al.

    Oral cancer is an aggressive malignancy that typically originates in surrounding tissues and spreads to the cervical lymph nodes, with no effective chemotherapy currently available to prevent its progression. Recent studies have explored selenium-containing compounds as potential chemotherapeutic agents. This study used a biological approach to synthesis bioinspired selenium nanoparticles (SeNPs), which were then analyzed using Fourier Transform Infrared Spectroscopy (FTIR), Ultraviolet-Visible (UV-Vis) spectroscopy, Energy Dispersive X-ray Spectroscopy (EDX), and Scanning Electron Microscopy (SEM).Their anticancer and anti-inflammatory activities were evaluated against human oral squamous cell carcinoma (HOSCC) KB-1 cell lines using the egg albumin assay, MTT assay, and cytotoxicity assay at concentrations of 15 and 31 µg/ml. The SeNPs significantly reduced cell viability, induced apoptosis, and exhibited potent anti-inflammatory effects. Morphological alterations, such as cytoplasmic membrane blebbing and cell shrinkage, were observed under both inverted phase contrast and fluorescence microscopy, indicating apoptotic cell death. These findings demonstrate that bioinspired selenium nanoparticles effectively induce cytotoxicity and apoptosis in HOSCC KB-1 cells, highlighting their potential as promising agents for oral cancer therapy.


  • Open Access

    Polyphenols Target Apoptosis and Cell Cycle Regulation in Various Cancer Models: Emphasis on Flavonoid Subclasses

    by Binoy Varghese Cheriyan, Kaniga Pandi, Dharshan Murali, Nesayan Boobalan, Jeevitha Harikrishnan, Deepshikaa Kannan, Lini Priyadharshini Christopher Jebaraj, Shamyuktha Munuswamy, Shagul Hameed Manaksha

    Cancer remains a major global health concern, driving the ongoing search for safer and more effective therapeutic agents. Naturally occurring polyphenolic compounds, including flavonoids, have gained considerable attention for their diverse pharmacological activities, particularly their ability to modulate cancer cell proliferation and apoptosis. This review summarizes current evidence on the anticancer potential of polyphenols and their subclasses across various human cancer cell lines, emphasizing their mechanisms in inducing programmed cell death and regulating cell cycle progression. Key flavonoids such as apigenin, quercetin, and kaempferol, along with other polyphenols like resveratrol and curcumin, exhibit significant anticancer effects through the activation of intrinsic and extrinsic apoptotic pathways and modulation of key cell cycle checkpoints. In vitro studies consistently demonstrate dose dependent cytotoxicity, mitochondrial membrane disruption, caspase activation, and regulation of p53, Bcl-2, cyclins, and CDKs in breast, colon, lung, prostate, and cervical cancer models. Despite encouraging preclinical outcomes, limitations such as poor bioavailability, inter-model variability, and lack of standardized protocols persist. Furthermore, synergistic interactions with conventional chemotherapeutics and advancements in delivery systems and molecular profiling tools may enhance their clinical relevance. Overall, polyphenols, particularly flavonoids, represent a promising class of anticancer agents warranting further translational and clinical exploration.


  • Open Access

    Extraction and Pharmacological Validation of Ursolic Acid from Hedyotis diffusa: A Molecular Docking Approach against Inflammation and Colon Cancer

    by Kaniga Pandi, Binoy Varghese Cheriyan, Abisheka Sree Anburaj, Lini Priyadharshini Christopher Jebaraj, Lavanya Murugesan, Kaviyashri Ramesh, Sam Jebaraj

    In traditional Chinese and Indian medical systems, Hedyotis diffusa is a well-known medicinal plant that is renowned for its wide range of pharmacological properties. The extraction, identification and pharmacological confirmation of ursolic acid a significant bioactive triterpenoid from H. diffusa are the main objectives of this investigation. The ethanolic extract was subjected to Soxhlet extraction, followed by column chromatography for the isolation of ursolic acid, which was subsequently confirmed by GC-MS analysis. A major peak at retention time 38.25 min and a molecular ion peak at m/z 456 confirmed its identity. The anti-inflammatory properties of ursolic acid were assessed using protein denaturation and membrane stabilization tests, showing notable suppression in a dose-dependent manner that was on par with that of regular diclofenac. Moreover, the MTT assay was used to evaluate its anticancer effectiveness against colon cancer cell lines (HT-29), where ursolic acid exhibited distinguished cytotoxicity with an IC50 value suggestive of strong anti-proliferative effects. To gain mechanistic insights, molecular docking studies were performed using AutoDock, targeting COX-2 (PDB ID: 1CX2) for inflammation and TNIK (PDB ID: 6GUE) for colon cancer. Ursolic acid displayed high binding affinities and stable interactions with both targets, indicating its potential dual inhibitory action. These results support the therapeutic relevance of ursolic acid from H. diffusa as a promising natural compound for managing inflammation and colon cancer.


  • Open Access

    Phytochemical and Biological Studies on the Whole Plant of Oldenlandia umbellate

    by Kaniga Pandi, Binoy Varghese Cheriyan, Devan Pandu, Ahamed Badhurudeen, Siva Shankar Gunasekaran, Suresh Kannan Manivannan, Prabavathi Loganathan, Jubilee Ramasamy, Yokesh Shanmugam, Maha Swetha Kannuchamy

    Background: Oldenlandia umbellate (Family: Rubiaceae) is a medicinal herb traditionally used in Indian systems of medicine for treating various ailments. Despite its folkloric use, comprehensive scientific validation of its pharmacognostic, phytochemical, and biological properties is limited. Aim: The present study aimed to evaluate the pharmacognostic characteristics, phytochemical profile, and multiple biological activities, namely antimicrobial, anti-inflammatory, anthelmintic, and anticancer potential of O. umbellate of various extracts. Methods: Collected and authenticated plant material underwent macroscopic and physicochemical evaluations for quality control. Extracts were prepared and subjected to qualitative phytochemical screening and quantitative estimations of total phenolic and flavonoid content. Antibacterial activity was assessed by the cup-plate method. Anti-inflammatory potential was determined using in vitro membrane stabilisation assays. Anthelmintic activity was evaluated using Pheretima posthuma as a test organism. Cytotoxicity against HT-29 colon cancer cell lines was tested using the MTT assay. Results: Phytochemical screening confirmed the presence of alkaloids, flavonoids, tannins, and saponins. The extract demonstrated significant antimicrobial zones of inhibition. Notable anti-inflammatory activity was observed, comparable to standard diclofenac sodium. The anthelmintic test showed dose-dependent paralysis and death times similar to piperazine citrate. In anticancer assays, the extract showed a strong dose-dependent cytotoxic effect on HT-29 cells, with a promising IC50 value. Conclusion: The results provide scientific validation for the traditional medicinal use of O. umbellata and confirm its multi-target biological activities. These findings suggest its potential as a natural therapeutic agent. Major Findings: The study highlights the potent antimicrobial, anti-inflammatory, anthelmintic, and anticancer activities of O. umbellata, supporting its role in herbal drug development. Future work should focus on the isolation, characterisation, and in vivo evaluation of its bioactive constituents.